Physitrack: Leading Healthcare strategist Michael Sloniewsky to head US operations.

Loading...
Loading...
SANTA MONICA, Calif.--(BUSINESS WIRE)--

Healthcare strategy and operations leader Michael Sloniewsky is to join Physitrack, the leading digital therapeutics provider, as General Manager of the US and Canada. He will head up the company's partnerships and future development across North America, from the company's US base in Santa Monica, CA.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20160219005309/en/

Sloniewsky, 44, joins from RMG, Inc., South Carolina, where he has played a key role in strategy and operations at corporate level, as well as within RMG's OsteoArthritis Centers of America business, and with US Physical Therapy USPH prior to that. Sloniewsky is a graduate of Columbia Business School's Executive Programs and Virginia Tech.

Visionary leader for Physitrack's US strategic partnerships.

"Michael is an admired strategist within the US healthcare sector", says Physitrack co-founder and CTO, Nathan Skwortsow.

"His focus, operational experience and leadership skills make him the perfect choice to guide Physitrack on the ground in its vital strategic collaborations with some of the world's largest corporates, including Apple AAPL. They also make Michael the ideal person to identify and develop new opportunities for Physitrack in North America, Canada and South America. With his vision and commitment, Michael will also be an inspirational figurehead and mentor for our global team."

Leading digital therapeutics platform.

Physitrack develops the world's leading digital therapeutics platform. It lets physiotherapists and other healthcare professionals build, prescribe and track video-based rehabilitation programs, delivered via web, iOS and Android apps. The company's library of original rehab video material now includes more than 2500 purpose-produced exercises.

As well as helping patients to adhere to their prescribed programs, Physitrack's tech enables them to feed back their performance, pain and comments to their healthcare provider, creating continuous visibility and communication throughout rehab. Physitrack also works with public and private healthcare institutions and researchers with data analysis for the enhancement of patient journeys and the optimization of rehabilitation costs.

US strategic partners key to Physitrack future.

Alongside the development of its branded platform, Physitrack has strategic collaboration efforts with international tech giants like Apple, expediting the rollout of its benefits to patients and practitioners, as well as to other healthcare stakeholders.

Michael Sloniewsky said, "I am delighted to come to Physitrack at this exciting and challenging point in the story of e-healthcare. Physitrack has proven its tech, its reputation as a maker of quality digital therapeutics content, and the opportunity to work alongside international mega brands like Apple, and to build out Physitrack further across the Americas is unmissable."

BACKGROUND INFORMATION:

Physitrack. The leader in digital therapeutics.

Physitrack (Bloomberg: 1297006D LN) is a privately held digital therapeutics provider with offices in Santa Monica, London, Amsterdam, New Delhi and Melbourne. The company develops iOS and web apps based on Physitrack's proprietary and clinically verified video exercises in areas such as musculoskeletal, neurological, paediatric and military rehabilitation.

Apple AAPL announced in 2015 it is working with a select group of business software and solution providers, including Physitrack.

Physitrack Limited
Frank von Zon
+1 415 230 0414
press@physitrack.com
http://physitrack.com
Video introduction to Physitrack:
http://www.physitrack.com/videos.html

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: Press Releases
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...